DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Jinhwan | ko |
dc.contributor.author | Ahn, Song Ih | ko |
dc.contributor.author | Kim, YongTae | ko |
dc.date.accessioned | 2024-08-06T09:00:15Z | - |
dc.date.available | 2024-08-06T09:00:15Z | - |
dc.date.created | 2024-08-06 | - |
dc.date.created | 2024-08-06 | - |
dc.date.issued | 2019-05 | - |
dc.identifier.citation | JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY, v.73, pp.8 - 18 | - |
dc.identifier.issn | 1226-086X | - |
dc.identifier.uri | http://hdl.handle.net/10203/321745 | - |
dc.description.abstract | Drug delivery to the brain remains challenging mainly due to the blood-brain barrier (BBB) that regulates the entrance of substances to the brain. Advances in nanotechnology have enabled the engineering of nanomedicines for biomedical applications including enhanced drug delivery into the brain. In this review, we describe strategies of nanomedicines engineered to traverse the BBB and deliver therapeutic molecules to target brain sites. We highlight the representative applications with materials including polymers, lipids, and inorganic elements for brain drug delivery. We finalize this review with the current challenges and future perspective of nanotherapeutics for advanced drug delivery to the brain. (C) 2019 The Korean Society of Industrial and Engineering Chemistry. Published by Elsevier B.V. All rights reserved. | - |
dc.language | English | - |
dc.publisher | ELSEVIER SCIENCE INC | - |
dc.title | Nanotherapeutics engineered to cross the blood-brain barrier for advanced drug delivery to the central nervous system | - |
dc.type | Article | - |
dc.identifier.wosid | 000462419300002 | - |
dc.identifier.scopusid | 2-s2.0-85060868116 | - |
dc.type.rims | ART | - |
dc.citation.volume | 73 | - |
dc.citation.beginningpage | 8 | - |
dc.citation.endingpage | 18 | - |
dc.citation.publicationname | JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY | - |
dc.identifier.doi | 10.1016/j.jiec.2019.01.021 | - |
dc.contributor.localauthor | Ahn, Song Ih | - |
dc.contributor.nonIdAuthor | Kim, Jinhwan | - |
dc.contributor.nonIdAuthor | Kim, YongTae | - |
dc.description.isOpenAccess | N | - |
dc.type.journalArticle | Review | - |
dc.subject.keywordAuthor | Nanomedicine | - |
dc.subject.keywordAuthor | Drug delivery | - |
dc.subject.keywordAuthor | Brain disease | - |
dc.subject.keywordAuthor | Blood-brain barrier | - |
dc.subject.keywordAuthor | Engineered nanoparticles | - |
dc.subject.keywordPlus | SOLID LIPID NANOPARTICLES | - |
dc.subject.keywordPlus | TARGETED THERAPY | - |
dc.subject.keywordPlus | GLIOMA THERAPY | - |
dc.subject.keywordPlus | PENETRATING PEPTIDE | - |
dc.subject.keywordPlus | ALZHEIMERS-DISEASE | - |
dc.subject.keywordPlus | NANOMEDICINE | - |
dc.subject.keywordPlus | LIPOSOMES | - |
dc.subject.keywordPlus | TUMOR | - |
dc.subject.keywordPlus | GENE | - |
dc.subject.keywordPlus | TRANSFERRIN | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.